| HELB is a feedback inhibitor of DNA end resection J Tkáč, G Xu, H Adhikary, JTF Young, D Gallo, C Escribano-Díaz, ... Molecular cell 61 (3), 405-418, 2016 | 172 | 2016 |
| CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition D Gallo, JTF Young, J Fourtounis, G Martino, A Álvarez-Quilón, C Bernier, ... Nature 604 (7907), 749-756, 2022 | 141 | 2022 |
| Haploinsufficiency of an RB–E2F1–Condensin II complex leads to aberrant replication and aneuploidy CH Coschi, CA Ishak, D Gallo, A Marshall, S Talluri, J Wang, MJ Cecchini, ... Cancer discovery 4 (7), 840-853, 2014 | 88 | 2014 |
| A role for USP7 in DNA replication M Jagannathan, T Nguyen, D Gallo, N Luthra, GW Brown, V Saridakis, ... Molecular and cellular biology 34 (1), 132-145, 2014 | 87 | 2014 |
| Rad5 recruits error-prone DNA polymerases for mutagenic repair of ssDNA gaps on undamaged templates D Gallo, TH Kim, B Szakal, X Saayman, A Narula, Y Park, D Branzei, ... Molecular cell 73 (5), 900-914. e9, 2019 | 65 | 2019 |
| Assembly of Slx4 signaling complexes behind DNA replication forks A Balint, TH Kim, D Gallo, JR Cussiol, FM Bastos de Oliveira, A Yimit, J Ou, ... The EMBO journal 34 (16), 2182-2197, 2015 | 54 | 2015 |
| Comparative chemogenomics to examine the mechanism of action of DNA-targeted platinum-acridine anticancer agents K Cheung-Ong, KT Song, Z Ma, D Shabtai, AY Lee, D Gallo, LE Heisler, ... ACS chemical biology 7 (11), 1892-1901, 2012 | 50 | 2012 |
| Flap endonuclease overexpression drives genome instability and DNA damage hypersensitivity in a PCNA-dependent manner JR Becker, D Gallo, W Leung, T Croissant, YM Thu, HD Nguyen, TK Starr, ... Nucleic acids research 46 (11), 5634-5650, 2018 | 48 | 2018 |
| Analysis of replicating yeast chromosomes by DNA combing D Gallo, G Wang, CM Yip, GW Brown Cold Spring Harbor Protocols 2016 (2), pdb. prot085118, 2016 | 37 | 2016 |
| Post-replication repair: Rad5/HLTF regulation, activity on undamaged templates, and relationship to cancer D Gallo, GW Brown Critical reviews in biochemistry and molecular biology 54 (3), 301-332, 2019 | 24 | 2019 |
| Sonic hedgehog accelerates DNA replication to cause replication stress promoting cancer initiation in medulloblastoma L Tamayo-Orrego, D Gallo, F Racicot, A Bemmo, S Mohan, B Ho, ... Nature cancer 1 (8), 840-854, 2020 | 23 | 2020 |
| Hyperphosphorylation by cyclin B/CDK1 in mitosis resets CUX1 DNA binding clock at each cell cycle L Sansregret, D Gallo, M Santaguida, L Leduy, R Harada, A Nepveu Journal of Biological Chemistry 285 (43), 32834-32843, 2010 | 19 | 2010 |
| Haploinsufficiency of an RB-E2F1-Condensin II complex leads to aberrant replication and aneuploidy. Cancer Discov. 2014; 4: 840–853. doi: 10.1158/2159-8290 CH Coschi, CA Ishak, D Gallo, A Marshall, S Talluri, J Wang, MJ Cecchini, ... CD-14-0215.[Abstract][CrossRef][Academic Search], 0 | 6 | |
| Single-molecule analysis of replicating yeast chromosomes D Gallo, G Wang, CM Yip, GW Brown Cold Spring Harbor Protocols 2016 (2), pdb. top077784, 2016 | 4 | 2016 |
| Fanconi anemia signaling and Mus81 cooperate to safeguard development and crosslink repair M Larin, D Gallo, L Tamblyn, J Yang, H Liao, N Sabat, GW Brown, ... Nucleic acids research 42 (15), 9807-9820, 2014 | 4 | 2014 |
| CDK12 loss leads to replication stress and sensitivity to combinations of the ATR inhibitor camonsertib (RP-3500) with PARP inhibitors J Setton, D Gallo, D Glodzik, B Kaiser, S Braverman, T Ubhi, S Fournier, ... European Journal of Cancer 174, S99-S100, 2022 | 3 | 2022 |
| Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR H Xu, E George, D Gallo, S Medvedev, X Wang, R Kryczka, ML Hyer, ... Research Square, rs. 3. rs-3854682, 2024 | 2 | 2024 |
| Preclinical development of PKMYT1 and WEE1 inhibitor combinations D Gallo, F Shah, R Stocco, C Bernier, J Fourtounis, A Shiwram, R Kryczka, ... Molecular Cancer Therapeutics 22 (12), 2023 | 2 | 2023 |
| Synthetic lethal strategies for the development of cancer therapeutics NYL Ngoi, D Gallo, C Torrado, M Nardo, D Durocher, TA Yap Nature Reviews Clinical Oncology, 1-19, 2024 | 1 | 2024 |
| Abstract C163: KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition ML Hyer, J Fourtounis, D Gallo, V Bhaskaran, R Stocco, R Kryczka, ... Molecular Cancer Therapeutics 22 (12_Supplement), C163-C163, 2023 | 1 | 2023 |
